阿拉斯加专责小组建议为联邦可能批准精神病疗法做好准备,敦促培训和公平获得治疗。 Alaska’s task force advises preparing for possible federal approval of psychedelic therapies, urging training and equitable access.

阿拉斯加州特别工作组已提出不具约束力的建议,为联邦可能批准诸如psilocybin和MDMA等精神病疗法做准备,强调预先规划安全、公平获得治疗的途径。 Alaska’s state task force has issued non-binding recommendations to prepare for potential federal approval of psychedelic therapies like psilocybin and MDMA, emphasizing proactive planning for safe, equitable access. 包括前代表Jennie Armstrong在内的该团体敦促国家为医疗许可以外的治疗师开展专门培训,重点是文化能力和多样性,使病人与提供者相匹配。 The group, including former representative Jennie Armstrong, urged the state to develop specialized training for therapists beyond medical licensure, focusing on cultural competence and diversity to match patients with providers. 建议旨在支持治疗包括创伤后精神紧张症、药物使用紊乱和抗治疗性抑郁症在内的病症,并列举了有希望的研究。 Recommendations aim to support treatment for conditions including PTSD, substance use disorders, and treatment-resistant depression, citing promising research. 虽然林业发展局尚未批准治疗办法,但申请尚待批准,工作队鼓励公众与立法者接触,以制定今后的政策。 Though the FDA has not yet approved the therapies, applications are pending, and the task force encourages public engagement with lawmakers to shape future policies.